• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Maesaka Kazuki  前阪 和城

ORCIDConnect your ORCID iD *help
… Alternative Names

前阪 和城  マエサカ カズキ

Less
Researcher Number 80974857
Other IDs
Affiliation (Current) 2025: 大阪大学, 医学部附属病院, 特任助教(常勤)
Affiliation (based on the past Project Information) *help 2023: 大阪大学, 医学部附属病院, 特任助教(常勤)
Review Section/Research Field
Principal Investigator
Basic Section 53010:Gastroenterology-related
Keywords
Principal Investigator
個別化医療 / 薬物療法 / 複合免疫療法 / バイオマーカー / 肝細胞癌
  • Research Projects

    (1 results)
  • Research Products

    (5 results)
  •  Development of new biomarkers to predict the therapeutic efficacy and prognosis of systemic chemotherapy for hepatocellular carcinomaPrincipal Investigator

    • Principal Investigator
      前阪 和城
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 53010:Gastroenterology-related
    • Research Institution
      Osaka University

All 2023

All Presentation

  • [Presentation] Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study2023

    • Author(s)
      Kazuki Maesaka, Hayato Hikita, Machiko Kai, Yuki Tahata, Kazuma Shinkai, Akira Doi, Kazuyoshi Ohkawa, Masanori Miyazaki, Hisashi Ishida, Kengo Matsumoto, Yasutoshi Nozaki, Takayuki Yakushijin, Ryotaro Sakamori, Takahiro Kodama, Tomohide Tatsumi, and Tetsuo Takehara
    • Organizer
      AASLD 2023
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-23K15068
  • [Presentation] 切除不能肝細胞癌に対するアテゾリズマブ+ベバシズマブ併用療法の治療効果予測因子の検討2023

    • Author(s)
      前阪 和城、疋田 隼人、竹原 徹郎
    • Organizer
      JDDW 2023
    • Data Source
      KAKENHI-PROJECT-23K15068
  • [Presentation] 切除不能肝細胞癌に対するアテゾリズマブ+ベバシズマブ併用療法と後治療としてのレンバチニブの治療成績2023

    • Author(s)
      前阪 和城、疋田 隼人、竹原 徹郎
    • Organizer
      第59回日本肝臓学会総会
    • Data Source
      KAKENHI-PROJECT-23K15068
  • [Presentation] Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study2023

    • Author(s)
      Kazuki Maesaka, Hayato Hikita, Machiko Kai, Yuki Tahata, Kazuma Shinkai, Akira Doi, Kazuyoshi Ohkawa, Masanori Miyazaki, Hisashi Ishida, Kengo Matsumoto, Yasutoshi Nozaki, Takayuki Yakushijin, Ryotaro Sakamori, Takahiro Kodama, Tomohide Tatsumi, and Tetsuo Takehara
    • Organizer
      APASL Oncology 2023
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-23K15068
  • [Presentation] 切除不能肝細胞癌に対するアテゾリズマブ+ベバシズマブ併用療法における抗生剤使用の影響2023

    • Author(s)
      前阪 和城、疋田 隼人、竹原 徹郎
    • Organizer
      第109回日本消化器病学会総会
    • Data Source
      KAKENHI-PROJECT-23K15068

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi